Institutionalizing Misinformation — The Dietary Supplement Listing Act of 2022-Reference-Cited by-同舟云学术

Institutionalizing Misinformation — The Dietary Supplement Listing Act of 2022

Published:2022-07-07 Issue:1 Volume:387 Page:3-5
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Cohen Pieter A.¹,Avorn Jerry¹,Kesselheim Aaron S.¹

Affiliation:

1. From Cambridge Health Alliance, Somerville (P.A.C.), and Harvard Medical School (P.A.C., J.A., A.S.K.) and the Program on Regulation, Therapeutics, and Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital (J.A., A.S.K.), Boston — all in Massachusetts.

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMp2205675

Reference4 articles.

1. Emergency Department Visits for Adverse Events Related to Dietary Supplements

2. Eight‐Fold Increase in Dietary Supplement–Related Liver Failure Leading to Transplant Waitlisting Over the Last Quarter Century in the United States

3. Breaking the gridlock: Regulation of dietary supplements in the United States

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nonclinical Safety Assessment of Botanical Products;A Comprehensive Guide to Toxicology in Nonclinical Drug Development;2024

2. Dietary Supplements for Weight Loss;Gastroenterology Clinics of North America;2023-06

3. Drug-Drug Interactions: How to Manage the Risk–A Stakeholder Approach;Clinical Therapeutics;2023-02

4. On opinion, freedom of speech and its responsibilities;Microbial Biotechnology;2022-07-13